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compared with expectorated, 7·7% (4·4 – 11·1), or induced spu-
tum, 11·7% (4·9 – 18·4) (Figure 3). There was a trend of decreasing
PCP prevalence amongst inpatients over time, from 28% (21 - 34)
in the 1990s to 9% (8 – 10) after 2005 (Figure 3), while the propor-
tion of inpatients on ART increased from 3·6% (1·8 – 6·6) to 24·3%
(9·8 – 38·7). The case fatality rate was 18·8% (11·0 – 26·5), and PCP
accounted for 6·5% (3·7 – 9·3) of study deaths. 29·5% of the 474 PCP
cases in whom additional testing was performed had a conﬁrmed
co-existent opportunistic pulmonary disease; TB was most com-
mon (14·8%), followed by bacterial pneumonia (8·7%) and Kaposi
sarcoma (4·1%).
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Conclusion: PCP is an important opportunistic infection
amongst HIV-infected adults in sub-Saharan Africa, particularly in
those admitted with respiratory symptoms. Improved access to
antiretroviral therapy and non-invasive diagnostics, such as PCR,
are needed.
http://dx.doi.org/10.1016/j.ijid.2016.02.694
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Background: Mucormycosis is an uncommon life-threatening
fungal infection. The major risk factors of this infection include
uncontrolled diabetes mellitus, prolonged steroid therapy, per-
sistent neutropenia, haematological malignancies, autoimmune
disorders, trauma, burn, and surgical wounds.
Methods & Materials: This retrospective study was performed
during a period of 10 years from April 2004 to March 2014.
Demographic data, laboratory data, clinical features, antifungal
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treatment, the need for surgical debridement, and the outcome
were collected and analysed.
Results: Data from 20 patients [13 males (65%), 7 females
(35%)] with a biopsy-proven diagnosis of mucormycosis were col-
lected. The mean age was 51.4 ± 9.7 years. Eighty-ﬁve percent
of patients had uncontrolled diabetes mellitus. The most com-
mon site of involvement was rhinocerebral region, occurring in
6 cases (30%). All the cases received amphotericin B’ but surgi-
cal debridement was performed on 10 patients (50%). The most
common involved sinuses were maxillary in 9 cases (45%). The
most common affected cranial nerve was the 3rd one, occurring
in 13 cases (65%). The most prevalent season of mucormycosis was
winter (40%). All of patients who underwent surgical debridement
plus antifungal treatment survived, compared to 50% of those who
received antifungal treatment alone (100% vs. 50%). Patients who
underwent surgical debridement survivedmore thanwho received
just medical management (P=0.033).
Conclusion: Our study showed that mucormycosis could be
a serious and potentially fatal infection, especially in diabetic
patients with poor control, and surgical management seems to be
necessary for better outcome.
http://dx.doi.org/10.1016/j.ijid.2016.02.695
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Background: Health care associated infections (HCAIs) are
important public health-related issues in developing countries.
There is limited data available on the incidence and burden of noso-
comial infection (NI) in the neurosurgical patients of South-East
Asian region.
Methods & Materials: We carried out a prospective HCAI
surveillance for 3 months duration, on all neurosurgical patients
admitted to a tertiary-care center of India. HCAIs were identiﬁed
using the National Healthcare Safety Network deﬁnitions of CDC.
The site-speciﬁc nosocomial infection rates and device utilization
ratios were calculated.
Results: A total of 245 patients with 4054 patient-days were
analyzed for HCAI. Fifteen NIs were identiﬁed in 15 patients. The
overall NI rate was 6.12% and 3.7 per 1000 patient-days. Catheter-
associated urinary tract infection (CA-UTI) was the most common
(86.67%) NI followed by ventilator-associated pneumonia (VAP;
6.67%). The CA-UTI rate was 15.78 per 1000 urinary catheter-
days. VAP rate was 1.69 per 1000 ventilator-days. No central
line-associated blood stream infection was identiﬁed. The ratios
of urinary catheter, central line, and ventilator utilization were
0.20, 0.06 and 0.15, respectively. K.pneumoniae (38.5%) was the
commonest organism causing CA-UTI followed by E.coli (30.8%),
Pseudomonas spp (15.4%) and P. vulgaris (7.70%). All the isolates
(100%) were found to be multidrug resistant.
Conclusion: This study generates a baseline data for the record
of device-associated infection, which will further help monitoring
its trend and antimicrobial resistance pattern.Moreover, this study
will help formulating the antibiotic policy in terms of prophylaxis
and preventive measures, which may reduce the morbidity and
mortality in neurosurgical patients.
http://dx.doi.org/10.1016/j.ijid.2016.02.696
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Background: Acinetobacter species are a heterogeneous group
of organisms that have emerged as signiﬁcant nosocomial
pathogens affecting patients with impaired host defenses. New-
borns, particularly are very prone to hospital acquired infections.
Till date,A. baumanniihasbeenpredominantly implicated inneona-
tal sepsis but “other species” within the genus have been reported
rarely. The persistence of endemicAcinetobacter strains in hospitals
seems to be related to their widespread resistance to antimi-
crobial agents. Since carbapenems are last resort antibiotics, this
study evaluated the dissemination of carbapenem-resistant genes
in cases of neonatal septicemia.
Methods & Materials: Acinetobacter spp. from blood of sep-
ticemic neonates was identiﬁed by ARDRA and susceptibility
tests were carried out by VITEK 2 system. Extended-spectrum -
lactamases, AmpCs, oxacillinases and metallo--lactamases were
detected phenotypically and genotypically and were subsequently
sequenced. Pulso-typing and plasmid characterization were also
carried out.
Results:A. baumanniiwas found tobepredominant genospecies
(72%) followed by A. calcoaceticus, A. lwofﬁi, 13TU, A. junni, 15TU,
A. haemolyticus and 14TU over the 7 years period. Fifty four
percent of the total isolates were meropenem-resistant. Compar-
ative analysis of susceptibility tests revealed that carbapenem
resistance (meropenem, imipenem) and aminoglycoside resistance
(amikacin, gentamicin) was signiﬁcantly lower in other species
of Acinetobacter against ACB (A. calcoaceticus-baumannii) com-
plex. The most prevalent oxacillinases were OXA-51-like (74%),
OXA-23-like (50%) and OXA-58-like (15%). New Delhi metallo-
-lactamase-1 was the dominant MBL (22%). NDM-1-harbouring
isolates also possessed blaVIM-2, blaPER-1, blaVEB-2, blaCTX-M-15, armA,
aac(6’)Ib, aac(6’)Ib-cr gene in various combinations. These isolates
wereclonallydiverse (Figure1)andharbouredplasmidsofdifferent
sizes.
